Drugs in MeSH Category Mutagens
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharms | CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 209872-002 | May 7, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 210046-002 | May 25, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 217150-001 | Sep 12, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xgen Pharms | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 211757-002 | Oct 18, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Roxane | CYCLOPHOSPHAMIDE | cyclophosphamide | TABLET;ORAL | 040032-002 | Aug 17, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
